Schröder FH - Search Results

1

Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer.

Schröder FH, Collette L, de Reijke TM, Whelan P. Schröder FH, et al. Br J Cancer. 2000 Jan;82(2):283-90. doi: 10.1054/bjoc.1999.0916. Br J Cancer. 2000. PMID: 10646878 Free PMC article. Clinical Trial.

2

Short-term versus long-term addition of cyproterone acetate to buserelin therapy in comparison with orchidectomy in the treatment of metastatic prostate cancer. European Organization for Research and Treatment of Cancer--Genitourinary Group.

Klijn JG, de Voogt HJ, Studer UE, Schröder FH, Sylvester R, De Pauw M. Klijn JG, et al. Among authors: schroder fh. Cancer. 1993 Dec 15;72(12 Suppl):3858-62. doi: 10.1002/1097-0142(19931215)72:12+<3858::aid-cncr2820721719>3.0.co;2-6. Cancer. 1993. PMID: 8252504 Clinical Trial.

3

Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences.

Collette L, Studer UE, Schröder FH, Denis LJ, Sylvester RJ. Collette L, et al. Among authors: schroder fh. Prostate. 2001 Jun 15;48(1):29-39. doi: 10.1002/pros.1078. Prostate. 2001. PMID: 11391684

4

Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up.

Korfage IJ, Essink-Bot ML, Janssens AC, Schröder FH, de Koning HJ. Korfage IJ, et al. Among authors: schroder fh. Br J Cancer. 2006 Apr 24;94(8):1093-8. doi: 10.1038/sj.bjc.6603057. Br J Cancer. 2006. PMID: 16622434 Free PMC article.

5

Antiandrogens as monotherapy for prostate cancer.

Schröder FH. Schröder FH. Eur Urol. 1998;34 Suppl 3:12-7. doi: 10.1159/000052291. Eur Urol. 1998. PMID: 9854190 Review.

6

Treatment of local-regional prostate cancer detected by PSA screening: benefits and harms according to prognostic factors.

Wever EM, Heijnsdijk EA, Draisma G, Bangma CH, Roobol MJ, Schröder FH, de Koning HJ. Wever EM, et al. Among authors: schroder fh. Br J Cancer. 2013 May 28;108(10):1971-7. doi: 10.1038/bjc.2013.198. Epub 2013 May 14. Br J Cancer. 2013. PMID: 23674085 Free PMC article.

7

Antiandrogenic substances in the management of prostatic cancer.

Schröder FH. Schröder FH. Recent Results Cancer Res. 1990;118:163-73. doi: 10.1007/978-3-642-83816-3_16. Recent Results Cancer Res. 1990. PMID: 2146723 Review.

8

European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.

Schröder FH, Denis LJ, Kirkels W, de Koning HJ, Standaert B. Schröder FH, et al. Cancer. 1995 Jul 1;76(1):129-34. doi: 10.1002/1097-0142(19950701)76:1<129::aid-cncr2820760120>3.0.co;2-1. Cancer. 1995. PMID: 8630864 Clinical Trial.

9

The future of endocrine treatment in early prostate cancer: concluding remarks.

Schröder FH. Schröder FH. Eur Urol. 1999;36 Suppl 2:27-30. doi: 10.1159/000052340. Eur Urol. 1999. PMID: 10529563

10

Screening for prostate cancer.

Postma R, Schröder FH. Postma R, et al. Among authors: schroder fh. Eur J Cancer. 2005 Apr;41(6):825-33. doi: 10.1016/j.ejca.2004.12.029. Eur J Cancer. 2005. PMID: 15808952 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page